Product Code: MD 4044
The pressure monitoring market is projected to reach USD 25.48 billion by 2032 from USD 14.56 billion in 2025, at a CAGR of 8.3% from 2025 to 2032.
Scope of the Report |
Years Considered for the Study | 2024-2032 |
Base Year | 2024 |
Forecast Period | 2024-2032 |
Units Considered | Value (USD billion) |
Segments | Product, Procedure, Therapeutic Application, End User, and Region |
Regions covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Technological innovations, such as the development of non-invasive, portable, and connected monitoring devices, have improved the accessibility and convenience of pressure monitoring in both clinical and home settings. Furthermore, the growth of telehealth services, increasing healthcare expenditures, and a heightened public awareness of preventive care are all contributing to early diagnosis and regular health monitoring. These factors are driving the adoption of pressure monitoring systems across various healthcare environments, thereby accelerating the growth of the pressure monitoring market.
The pressure monitoring market is experiencing substantial growth, driven by several key factors. A major contributor to this trend is the increasing global prevalence of chronic diseases such as hypertension, cardiovascular disorders, and respiratory conditions, which require continuous and accurate pressure monitoring for effective management. The aging population also plays a significant role in this demand, as older adults are more vulnerable to these health issues.
Additionally, advancements in technology have led to the creation of non-invasive, portable, and smart devices that enhance patient comfort and facilitate remote monitoring. This aligns with the rising trend of telehealth and home-based care. Moreover, increasing healthcare expenditures, expanding healthcare infrastructure, and heightened awareness about early diagnosis and preventive care are also fueling market growth worldwide.
Together, these factors, combined with an older population that needs ongoing health management, are accelerating the adoption of pressure monitoring systems across various healthcare settings.
Based on products, pulmonary pressure monitors accounted for the second-largest share in the pressure monitoring market.
The growth of pulmonary pressure monitoring within the broader pressure monitoring market is being driven by the rising incidence of pulmonary hypertension and other respiratory-related complications, especially among aging populations and patients with chronic obstructive pulmonary disease (COPD) or heart failure. There is an increasing emphasis on the early detection of pulmonary vascular abnormalities to prevent severe outcomes, which is prompting healthcare systems to adopt more precise and real-time pulmonary pressure assessment tools. The shift towards minimally invasive and implantable monitoring technologies has further accelerated this adoption, particularly in critical care and cardiopulmonary settings. Additionally, clinical guidelines and research are increasingly supporting the importance of pulmonary pressure monitoring in optimizing treatment plans, thus driving investment and innovation in this niche yet vital segment of the market.
Based on procedures, invasive procedures registered the highest CAGR during the forecast period.
The increasing demand for real-time, high-precision monitoring in critical care and surgical settings is driving the growth of invasive procedures in the pressure monitoring market. Techniques such as arterial and intracranial pressure measurements are essential for managing patients with severe cardiovascular, neurological, or traumatic conditions, as immediate and accurate readings can significantly impact their outcomes.
The rise in complex surgeries, particularly among aging populations and patients with multiple comorbidities, has heightened the need for continuous intraoperative and ICU monitoring. Additionally, the growing sophistication of critical care units and the greater availability of specialized medical personnel in developed healthcare systems are supporting the wider adoption of invasive monitoring methods.
As hospitals and surgical centers prioritize patient safety and precision in diagnosis and treatment, invasive pressure monitoring remains a vital component in high-acuity clinical environments.
Based on therapeutic applications, respiratory disorders hold the largest share of the pressure monitoring market.
The rise in respiratory disorders is significantly driving the demand for pressure monitoring systems, which is closely linked to increasing environmental and lifestyle-related health challenges. Factors such as rising air pollution, occupational exposure to harmful particles, smoking, and the long-term effects of respiratory infections have contributed to a surge in chronic respiratory diseases like COPD, asthma, and sleep apnea.
These conditions often necessitate precise and continuous monitoring of intrathoracic and airway pressures to effectively manage ventilation and oxygen therapy. Additionally, the growing use of mechanical ventilation and non-invasive respiratory support in both hospital and home care settings has led to a substantial increase in the need for pressure monitoring systems.
As healthcare providers focus on early intervention and proactive disease management, accurate pressure measurement tools have become essential for improving clinical outcomes and reducing hospital readmissions for patients with respiratory conditions.
By end user, home care settings dominated the pressure monitoring market in 2024.
The growth of pressure monitoring in home care settings is driven by several key factors. First, there is an increasing prevalence of chronic diseases, such as hypertension and cardiovascular disorders, which require continuous monitoring and make home-based solutions more appealing. Additionally, technological advancements have led to the development of user-friendly, portable, and accurate monitoring devices that facilitate self-management and reduce the need for frequent hospital visits.
Furthermore, the aging population prefers to receive care in the comfort of their own homes, which further boosts the demand for homecare monitoring solutions. Changes in healthcare policies and reimbursement structures are also evolving to support home-based care, making it a more viable option for both patients and providers. Collectively, these factors contribute to the growing role of pressure monitoring in home care settings.
By region, North America accounted for the largest share of the pressure monitoring market in 2024.
The growth of the pressure monitoring market in North America is driven by a strong emphasis on advanced healthcare technologies and patient-centered care models. Increased investments in healthcare IT infrastructure have enabled the integration of pressure monitoring devices with electronic health records and telehealth platforms, resulting in more efficient and coordinated patient management. Moreover, strict regulatory frameworks and quality standards in North America promote the adoption of highly reliable and innovative monitoring solutions.
The shift towards value-based care is encouraging healthcare providers to utilize continuous pressure monitoring to improve clinical outcomes and reduce hospital readmissions. Additionally, awareness campaigns focused on cardiovascular health, as well as government programs aimed at early disease detection, are increasing the demand for pressure monitoring devices in both clinical and home care settings.
A breakdown of the primary participants (supply side) for the pressure monitoring market referred to in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
The key players in the pressure monitoring market are Medtronic (US), Omron Corporation (Japan), Dragerwerk AG & Co. KGaA (Germany), Abbott (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Baxter (US), Terumo Corporation (Japan), BD (US), Nihon Kohden Corporation (Japan), Integra LifeSciences Corporation (US), Zeiss Group (Germany), Boston Scientific Corporation (US), HONSUN (China), A&D Company (Japan), Reichert, Inc. (US), Nonin. (US), Mehra Eyetech Pvt. Ltd. (India), Rossmax International Ltd. (China), Microlife Corporation. (China), SunTech Medical, Inc. (US), PAUL HARTMANN Asia-Pacific Ltd. (Canada), Icare Finland Oy (Finland), and iHealth Labs Inc. (US).
Research Coverage
The report analyzes the pressure monitoring market and estimates its size and future growth potential based on various segments such as product, procedure, therapeutic area, end user, and region. It also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report is designed to assist both market leaders and new entrants by providing valuable insights into the overall pressure monitoring market, including detailed revenue estimates for its subsegments. It will help stakeholders comprehend the competitive landscape, allowing them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, enabling stakeholders to understand current market trends and dynamics.
This report provides insights into the following pointers:
- Analysis of key drivers (growing prevalence of chronic diseases, technological advancements and integration with digital health platforms, shift towards home healthcare and remote monitoring, and aging population and increased healthcare expenditure), restraints (regulatory and compliance challenges and data privacy and security concerns), opportunities (development of non-invasive and wearable pressure monitoring devices and growth in emerging markets and telehealth infrastructure), and challenges (limited availability of skilled professionals)
- Market Penetration: It provides detailed information on products available from major players in the global pressure monitoring market. The report covers various segments, including products, procedures, therapeutic areas, end users, and regions
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global pressure monitoring market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, procedure, therapeutic application, end user, and region
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global pressure monitoring market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global pressure monitoring market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 MARKET LIMITATIONS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH APPROACH
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Breakdown of primaries
- 2.2 MARKET SIZE ESTIMATION
- 2.3 GROWTH FORECAST
- 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.5 KEY INDUSTRY INSIGHTS
- 2.6 RESEARCH IMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7 RISK ASSESSMENT
- 2.8 STUDY ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 PRESSURE MONITORING MARKET OVERVIEW
- 4.2 NORTH AMERICA: PRESSURE MONITORING MARKET, BY PRODUCT & COUNTRY (2024)
- 4.3 PRESSURE MONITORING MARKET: REGIONAL MIX, 2025 VS. 2032
- 4.4 PRESSURE MONITORING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.5 PRESSURE MONITORING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Growing prevalence of chronic diseases
- 5.2.1.2 Integration with digital health platforms and rising technological advancements
- 5.2.1.3 Gradual shift towards remote monitoring and home healthcare
- 5.2.1.4 Expanding geriatric population and rising healthcare expenditure
- 5.2.2 RESTRAINTS
- 5.2.2.1 Stringent regulatory guidelines for commercialization of medical devices
- 5.2.2.2 Concerns associated with data privacy & security
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Development of non-invasive & wearable pressure monitoring devices
- 5.2.3.2 Expansion of telehealth infrastructure in emerging economies
- 5.2.4 CHALLENGES
- 5.2.4.1 Limited availability of skilled professionals
- 5.3 INDUSTRY TRENDS
- 5.3.1 INTEGRATION OF WIRELESS CONNECTIVITY AND IOT IN PRESSURE MONITORING DEVICES
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
- 5.4.1.1 MEMS (Micro-Electro-Mechanical Systems) sensors
- 5.4.1.2 Wireless connectivity & cloud integration
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
- 5.4.2.1 AI & predictive analytics
- 5.4.2.2 Wearable electronics & flexible materials
- 5.5 PORTER'S FIVE FORCES ANALYSIS
- 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.5.2 BARGAINING POWER OF BUYERS
- 5.5.3 BARGAINING POWER OF SUPPLIERS
- 5.5.4 THREAT OF SUBSTITUTES
- 5.5.5 THREAT OF NEW ENTRANTS
- 5.6 REGULATORY LANDSCAPE
- 5.6.1 REGULATORY FRAMEWORK
- 5.6.1.1 North America
- 5.6.1.2 Europe
- 5.6.1.3 Asia Pacific
- 5.6.1.3.1 Japan
- 5.6.1.3.2 China
- 5.6.1.3.3 India
- 5.6.1.4 Latin America
- 5.6.1.5 Middle East & Africa
- 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.7 PATENT ANALYSIS
- 5.7.1 PATENT PUBLICATION TRENDS FOR BLOOD PRESSURE MONITORING MARKET
- 5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA FOR HS CODE 901890, 2020-2025
- 5.8.2 EXPORT DATA FOR HS CODE 901890, 2020-2025
- 5.9 PRICING ANALYSIS
- 5.9.1 INDICATIVE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
- 5.9.2 INDICATIVE SELLING PRICE TREND OF PRESSURE MONITORING PRODUCTS, BY REGION
- 5.10 KEY CONFERENCES & EVENTS, 2025-2026
- 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.11.2 BUYING CRITERIA
- 5.12 UNMET NEEDS/END-USER EXPECTATIONS IN PRESSURE MONITORING MARKET
- 5.13 IMPACT OF AI/GENERATIVE AI ON PRESSURE MONITORING MARKET
- 5.14 VALUE CHAIN ANALYSIS
- 5.15 SUPPLY CHAIN ANALYSIS
- 5.16 ECOSYSTEM ANALYSIS
- 5.17 CASE STUDY ANALYSIS
- 5.17.1 CASE STUDY 1: MEDTRONIC INTEGRATED CRITICAL CARE PLATFORM CAPABILITIES INTO PRESSURE MONITORING DEVICES
- 5.17.2 CASE STUDY 2: IMPLEMENTATION OF ADVANCED INVASIVE PRESSURE MONITORING SOLUTIONS ACROSS CRITICAL CARE SETTINGS BY GE HEALTHCARE
- 5.17.3 CASE STUDY 3: ENHANCED ACCURACY & USABILITY IN HOME MONITORING BY OMRON HEALTHCARE
- 5.18 ADJACENT MARKETS FOR PRESSURE MONITORING MARKET
- 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.20 INVESTMENT & FUNDING SCENARIO
- 5.21 IMPACT OF 2025 US TARIFF ON PRESSURE MONITORING MARKET
- 5.21.1 KEY TARIFF RATES
- 5.21.2 PRICE IMPACT ANALYSIS
- 5.21.3 IMPACT ON COUNTRY/REGION
- 5.21.3.1 North America
- 5.21.3.2 Europe
- 5.21.3.3 Asia Pacific
- 5.21.4 IMPACT ON END-USER INDUSTRIES
- 5.21.4.1 Hospitals
- 5.21.4.2 Home care settings
- 5.21.4.3 Ambulatory care centers
6 PRESSURE MONITORING MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 DEVICES
- 6.2.1 BLOOD PRESSURE MONITORS, BY TYPE
- 6.2.1.1 Sphygmomanometers
- 6.2.1.1.1 Rising rates of hypertension to boost demand
- 6.2.1.2 Blood pressure transducers
- 6.2.1.2.1 Conversion of physiological blood pressure signals into electronic outputs to fuel market
- 6.2.1.3 Ambulatory blood pressure monitors
- 6.2.1.3.1 Growing focus on RPM services to drive market
- 6.2.1.4 Automated blood pressure monitors
- 6.2.1.4.1 Increasing preference for personalized health management to propel market
- 6.2.1.5 Cuffless blood pressure monitors
- 6.2.1.5.1 Integration of technological advancements into wearable devices to fuel market
- 6.2.2 BLOOD PRESSURE MONITORS, BY TECHNOLOGY
- 6.2.2.1 Digital blood pressure monitors
- 6.2.2.1.1 Improved accuracy & precision to support market growth
- 6.2.2.2 Aneroid blood pressure monitors
- 6.2.2.2.1 Proven efficacy across clinical settings to boost demand
- 6.2.2.3 Wearable blood pressure monitors
- 6.2.2.3.1 Cuff-based blood pressure monitors
- 6.2.2.3.2 Cuffless blood pressure monitors
- 6.2.2.3.2.1 Wrist-based monitors
- 6.2.2.3.2.1.1 Advancements in sensor technology and miniaturization to fuel uptake
- 6.2.2.3.2.2 Finger-based Monitors
- 6.2.2.3.2.2.1 Digital integration to accelerate demand
- 6.2.2.3.2.3 Arm band-based monitors
- 6.2.2.3.2.3.1 Continuous monitoring and fitness health tracking insights to boost demand
- 6.2.3 INTRAOCULAR PRESSURE MONITORS
- 6.2.3.1 Increasing prevalence of glaucoma to boost demand
- 6.2.4 PULMONARY PRESSURE MONITORS
- 6.2.4.1 Oximeters
- 6.2.4.1.1 Rising incidence of respiratory & infectious diseases to propel market
- 6.2.4.2 Capnography
- 6.2.4.2.1 Increasing prevalence of COPD and ARDS to support market uptake
- 6.2.4.3 Spirometers
- 6.2.4.3.1 Introduction of portable and digital spirometers to aid market growth
- 6.2.5 INTRACRANIAL PRESSURE MONITORS
- 6.2.5.1 Surge in neurological disorders to boost demand
- 6.2.6 OTHER MONITORING DEVICES
- 6.3 ACCESSORIES
- 6.3.1 BLOOD PRESSURE ACCESSORIES, BY TYPE
- 6.3.1.1 Blood pressure/cardiac monitoring accessories
- 6.3.1.1.1 Blood pressure cuffs
- 6.3.1.1.1.1 Availability of manual & automatic models to aid market
- 6.3.1.1.2 Bulbs
- 6.3.1.1.2.1 Utilized in conjunction with sphygmomanometers for accurate measurement to drive market
- 6.3.1.1.3 Manometers
- 6.3.1.1.3.1 Rising demand due to hypertension to support market growth
- 6.3.1.1.4 Tubes & valves
- 6.3.1.1.4.1 Focus on accurate measurement in clinical settings to fuel uptake
- 6.3.1.2 Intraocular pressure monitoring accessories
- 6.3.1.2.1 Tip covers/Tonocovers
- 6.3.1.2.1.1 Advancements in ocular surgery to drive market
- 6.3.1.2.2 Prisms
- 6.3.1.2.2.1 Increasing incidence of cataracts to fuel uptake
- 6.3.1.2.3 Sensors
- 6.3.1.2.3.1 Integration of IOP sensors into clinical practice to support market uptake
- 6.3.1.3 Pulmonary pressure monitoring accessories
- 6.3.1.3.1 Mouthpieces
- 6.3.1.3.1.1 Growing effectiveness in non-invasive ventilation to boost demand
- 6.3.1.3.2 Filters
- 6.3.1.3.2.1 Growing emphasis on infection control practices to aid market
- 6.3.1.3.3 Nasal probes & plugs
- 6.3.1.3.3.1 Focus on enhanced respiratory airflow and monitoring to fuel market
- 6.3.1.4 Other pressure monitoring accessories
- 6.3.2 ACCESSORIES, BY USABILITY
- 6.3.2.1 Disposable accessories
- 6.3.2.1.1 Increasing adoption of single-use accessories for patient safety to boost demand
- 6.3.2.2 Reusable accessories
- 6.3.2.2.1 Emphasis on sustainable healthcare practices to support market growth
7 PRESSURE MONITORING MARKET, BY PROCEDURE
- 7.1 INTRODUCTION
- 7.2 INVASIVE PROCEDURES
- 7.2.1 ABILITY TO BALANCE CLINICAL ACCURACY & PATIENT SAFETY IN HIGH-ACUITY PRESSURE MONITORING SYSTEMS TO DRIVE MARKET
- 7.3 NON-INVASIVE PROCEDURES
- 7.3.1 AI & ML INTEGRATION WITH REAL-MONITORING INSIGHTS TO BOOST DEMAND
8 PRESSURE MONITORING MARKET, BY THERAPEUTIC APPLICATION
- 8.1 INTRODUCTION
- 8.2 RESPIRATORY DISORDERS
- 8.2.1 INCREASING INCIDENCE OF COPD AND ASTHMA TO DRIVE MARKET
- 8.3 GLAUCOMA
- 8.3.1 DEVELOPMENT OF MINIMALLY INVASIVE SENSOR-BASED DEVICES TO FUEL UPTAKE
- 8.4 CARDIAC DISORDERS
- 8.4.1 HIGH PREVALENCE OF MYOCARDIAL INFARCTION AND HYPERTENSION TO PROPEL MARKET
- 8.5 NEUROLOGICAL DISORDERS
- 8.5.1 CASES OF TBHI AND HEMORRHAGE TO FUEL ADOPTION
- 8.6 DIALYSIS
- 8.6.1 INCREASING PREVALENCE OF CKD TO SUPPORT MARKET GROWTH
- 8.7 OTHER THERAPEUTIC APPLICATIONS
9 PRESSURE MONITORING MARKET, BY END USER
- 9.1 INTRODUCTION
- 9.2 HOSPITALS & CLINICS
- 9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO DRIVE MARKET
- 9.3 AMBULATORY CARE CENTERS
- 9.3.1 GROWING DEMAND FOR REAL-TIME PATIENT MONITORING ACROSS CRITICAL CARE TO FUEL MARKET
- 9.4 HOME CARE SETTINGS
- 9.4.1 ENHANCED PATIENT CONVENIENCE & SAFETY TO PROPEL MARKET
- 9.5 URGENT CARE SETTINGS
- 9.5.1 RISING NEED FOR TIMELY DECISION-MAKING FOR TRAUMA CASES TO BOOST DEMAND
- 9.6 PRIMARY CENTERS
- 9.6.1 GROWING FOCUS ON ENHANCED PATIENT OUTCOMES TO SUPPORT MARKET UPTAKE
- 9.7 OTHER END USERS
10 PRESSURE MONITORING MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
- 10.2.2.1 Established healthcare infrastructure and high volume of chronic diseases to drive market
- 10.2.3 CANADA
- 10.2.3.1 Favorable government initiatives for digital health integration to boost demand
- 10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
- 10.3.2.1 Increasing cases of hypertension to fuel market
- 10.3.3 UK
- 10.3.3.1 High burden of contagious diseases to boost demand
- 10.3.4 FRANCE
- 10.3.4.1 Expansive growth in medical devices industry to aid market
- 10.3.5 ITALY
- 10.3.5.1 Adoption of cuffless blood pressure monitoring devices to drive market
- 10.3.6 SPAIN
- 10.3.6.1 Government initiatives on advanced medical equipment to fuel uptake
- 10.3.7 REST OF EUROPE
- 10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
- 10.4.2.1 Favorable policies for healthcare modernization to support market growth
- 10.4.3 JAPAN
- 10.4.3.1 Increasing geriatric population and rise in age-associated target conditions to boost demand
- 10.4.4 INDIA
- 10.4.4.1 Improvements in healthcare infrastructure to fuel market
- 10.4.5 SOUTH KOREA
- 10.4.5.1 Growing focus on national health programs and public health initiatives to drive market
- 10.4.6 AUSTRALIA
- 10.4.6.1 Increasing funding investments for non-invasive monitoring technologies to boost demand
- 10.4.7 REST OF ASIA PACIFIC
- 10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
- 10.5.2.1 Growing focus on home healthcare to support market
- 10.5.3 MEXICO
- 10.5.3.1 Increasing focus on telehealth integration to drive market
- 10.5.4 REST OF LATIN AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
- 10.6.2.1 Kingdom of Saudi Arabia (KSA)
- 10.6.2.1.1 Increasing cases of infectious diseases to boost demand
- 10.6.2.2 United Arab Emirates (UAE)
- 10.6.2.2.1 Increasing prevalence of CVD to drive market
- 10.6.2.3 Other GCC Countries
- 10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
- 11.1 OVERVIEW
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.3 REVENUE ANALYSIS
- 11.4 MARKET SHARE ANALYSIS
- 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.5.5.1 Company footprint
- 11.5.5.2 Region footprint
- 11.5.5.3 Product footprint
- 11.5.5.4 Procedure type footprint
- 11.5.5.5 Therapeutic application footprint
- 11.5.5.6 End-user footprint
- 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 DYNAMIC COMPANIES
- 11.6.3 STARTING BLOCKS
- 11.6.4 RESPONSIVE COMPANIES
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 11.6.5.1 Detailed list of key startups/SME players
- 11.6.5.2 Competitive benchmarking of startups/SMEs
- 11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
- 11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
- 11.9 R&D ASSESSMENT OF KEY PLAYERS
- 11.10 COMPETITIVE SCENARIO
- 11.10.1 PRODUCT LAUNCHES & APPROVALS
- 11.10.2 DEALS
- 11.10.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 MEDTRONIC
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.3.1 Product approvals
- 12.1.1.3.2 Deals
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 KONINKLIJKE PHILIPS N.V.
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 Recent developments
- 12.1.2.3.1 Deals
- 12.1.2.3.2 Expansions
- 12.1.2.4 MnM view
- 12.1.2.4.1 Key strengths
- 12.1.2.4.2 Strategic choices
- 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 GE HEALTHCARE
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 Recent developments
- 12.1.3.3.1 Product approvals
- 12.1.3.3.2 Deals
- 12.1.3.4 MnM view
- 12.1.3.4.1 Key strengths
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 OMRON CORPORATION.
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 Recent developments
- 12.1.4.4 MnM view
- 12.1.4.4.1 Key strengths
- 12.1.4.4.2 Strategic choices
- 12.1.4.4.3 Weaknesses & competitive threats
- 12.1.5 DRAGERWERK AG & CO. KGAA
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 MnM view
- 12.1.5.3.1 Key strengths
- 12.1.5.3.2 Strategic choices
- 12.1.5.3.3 Weaknesses & competitive threats
- 12.1.6 ABBOTT
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 Recent developments
- 12.1.6.3.1 Product approvals
- 12.1.6.3.2 Deals
- 12.1.7 BAXTER INTERNATIONAL, INC.
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.8 TERUMO CORPORATION
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.8.3 Recent developments
- 12.1.9 BECTON, DICKINSON AND COMPANY (BD)
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.9.3 Recent developments
- 12.1.10 NIHON KOHDEN CORPORATION
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.11 INTEGRA LIFESCIENCES CORPORATION
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.12 ZEISS GROUP
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.13 BOSTON SCIENTIFIC CORPORATION
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 ICU MEDICAL, INC.
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.14.3 Recent development
- 12.1.15 MASIMO CORPORATION
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.2 OTHER PLAYERS
- 12.2.1 REICHERT, INC.
- 12.2.2 NONIN
- 12.2.3 NATUS
- 12.2.4 HONSUN
- 12.2.5 ROSSMAX INTERNATIONAL LTD.
- 12.2.6 MICROLIFE CORPORATION
- 12.2.7 A&D COMPANY
- 12.2.8 PAUL HARTMANN ASIA-PACIFIC LTD.
- 12.2.9 ICARE FINLAND OY.
- 12.2.10 IHEALTH LABS INC.
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 AUTHOR DETAILS